Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery

Clinical trial NCT02450487 · COMPLETED

Trial details

NCT number: NCT02450487
Sponsor: University of Sao Paulo
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pain Other Surgical Procedures Impacted Third Molar Tooth Cytochrome P450 CYP2C9 Enzyme Deficiency

Start date: 2012-10-01
Primary completion: 2015-10-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.